a commercial stage medical technology company, which focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MGRPX | 58.27 | 1.16 | +2.03% |
Morgan Stanley Inst Growth R6 | |||
CFXRX | 14.47 | 0.09 | +0.63% |
Columbia Flexible Capital Income Inst2 | |||
IVEIX | 9.98 | 0.06 | +0.60% |
Delaware Climate Solutions I | |||
BGEZX | 9.50 | 0.02 | +0.21% |
Baillie Gifford Emer Mkt Ex Chn K | |||
AEDRX | 34.72 | -0.04 | -0.12% |
Invesco EQV European Equity R |
A.I.dvisor tells us that TELA and GH have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELA and GH's prices will move in lockstep.
Ticker / NAME | Correlation To TELA | 1D Price Change % | ||
---|---|---|---|---|
TELA | 100% | -0.34% | ||
GH - TELA | 27% Poorly correlated | N/A | ||
SIBN - TELA | 27% Poorly correlated | -1.38% | ||
TFX - TELA | 27% Poorly correlated | -2.92% | ||
NEOG - TELA | 26% Poorly correlated | -1.26% | ||
ALC - TELA | 25% Poorly correlated | +0.08% | ||
More |